AMD/RETINA
A wearable collision warning device reduced the rates of collisions with daily obstacles in individuals who are visually impaired, according to a study.
In this double-masked randomized clinical trial, 31 participants used a collision warning device involving a chest-mounted video camera that detects collision hazards during a 4 week period. While in active mode the device would alert wearers of potential collisions and while in silent mode the device would still detect collision but not alert wearers.…
featured stories
View Conference Coverage
Take a look at some of our conference coverage, visit our roundup section.
Videos
-
Jan 22, 2020
Implantable Miniature Telescope for Advanced AMD
-
Jan 22, 2020
Treating AMD Patients with New Technology
-
Jan 22, 2020
How do you Verify That a Patient Has AMD?
-
Jan 22, 2020
Age-related Drusen or Pathologic Drusen?
-
Jan 22, 2020
What is DME?
-
Jan 22, 2020
ENTV DME Treatment Strategy
Conference Roundup
- Jun 04, 2021
Is AI inevitable in ophthalmology? That’s up for debate
During a session at Hawaiian Eye & Retina 2021, Dr Robert Chang and Dr Jason M. Bacharach debated for and against, respectively, the use of artificial intelligence in ophthalmology.
In this light-hearted yet informative session, both doctors…
-
Debunking intraocular ocular tumor misconceptions
Jun 01, 2021
-
-
-
Experts discuss anti-VEGF therapy for DME management
May 23, 2021
Journal Scan
- Jul 23, 2021
Wearable collision warning device helps visually impaired individuals
A wearable collision warning device reduced the rates of collisions with daily obstacles in individuals who are visually impaired, according to a study.
In this double-masked randomized clinical trial, 31…
Trending Topics
- Jul 15, 2021
FDA grants breakthrough therapy designation for ALK-001 for Stargardt Disease
The U.S. Food and Drug Administration has granted breakthrough therapy designation to ALK-001 (C20-D3-vitamin A; Alkeus Pharmaceuticals) for the…
